Delivery Order SPE2DB22D3016-SPE2DB26FAAD1
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,855.22 on September 4, 2025, for the supply of Triumeq 600-50-300 mg tablets in quantities of 30 units. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in units of 30, with a ceiling value of $8,765.93. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,537.65 to AmerisourceBergen Drug Corp for the supply of Triumeq 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of June 25, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $6,519.84 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger federal contract vehicle. This award falls under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s, with a ceiling value of $6,519.84 and an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,519.84 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 13, 2025, with a completion date of August 14, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an expansive $999.99 billion pharmaceutical supply agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Triumeq 600-50-300 mg tablets (30-count units) with a ceiling value of $35,571.24. This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and is scheduled for completion by September 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $23,257.91 to AmerisourceBergen Drug Corp for 30-unit supplies of TRIUMEQ 600-50-300 mg tablets. This contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $33,210.45 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAD1Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Triumeq 600-50-300 mg tablets (30-count units) valued at $3,625.03. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for military and veteran healthcare systems through its extensive federal contract portfolio. The company's contract awards with the DLA demonstrate its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains, from brand-name and generic medications to vaccines and specialized medical supplies. The delivery of Triumeq, an antiretroviral medication used in HIV treatment, reflects AmerisourceBergen's role as a key vendor supporting the Defense Health Agency and other federal healthcare systems' pharmaceutical requirements. All of the company's reviewed federal awards have been competitively awarded with firm fixed pricing, indicating its proven ability to meet federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 10/17/25 |